Active, Not Recruiting
Study of Durvalumab Given With Chemotherapy, Durvalumab in Combination With Tremelimumab Given With Chemotherapy, or Chemotherapy in Patients With Unresectable Urothelial Cancer
NCT03682068
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +10 more
- Locations
-
- Research Site Birmingham, Alabama, United States
- Research Site Bakersfield, California, United States
- Research Site Fullerton, California, United States
- Research Site Los Angeles, California, United States